SSA
VIVE

Schonfeld Strategic Advisors’s VIVEVE MED INC VIVE Stock Holding History

Schonfeld Strategic Advisors’s Portfolio VIVE Stock Details VIVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-110
Closed -$790K – 817
2017
Q2 		$790K Buy
+110
New +$820K 0.08% 316

Other funds holding VIVE

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IG
ING Group Amsterdam, Netherlands $16.4B AUM 34.6% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return

Schonfeld Strategic Advisors's VIVE Position: Q3 2017 in Review

Schonfeld Strategic Advisors sold out of VIVEVE MED INC (VIVE) in Q3 2017, closing a stake of 110 shares — an estimated $790K sold.

Schonfeld Strategic Advisors first reported a position in VIVE in Q2 2017 and held it in 1 quarter. The position peaked at $790K in Q2 2017. 48 funds tracked by Wall St. Rank hold VIVE as of Q3 2017.

  • Schonfeld Strategic Advisors reported no remaining VIVEVE MED INC position as of Q3 2017 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 110 VIVEVE MED INC shares in Q3 2017, an estimated $790K.
  • Schonfeld Strategic Advisors first reported a position in VIVEVE MED INC in Q2 2017 and held it in 1 quarter.
  • Schonfeld Strategic Advisors's VIVEVE MED INC position peaked at $790K in Q2 2017.
  • 48 funds tracked by Wall St. Rank held VIVEVE MED INC as of Q3 2017.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2017, filed 14 Nov 2017.